"Advanced ENT and Allergy's expert otolaryngologists and allergists provide a full spectrum of ear, nose and throat care as well as a full complement of head and neck surgery. In addition to general ENT, we have specialized medical expertise available through our five centers of excellence: The Allergy Center, The Hearing Center, The Sinus Center, The Thyroid Center, The Pediatric Center, Clinical Research and Aesthetic Center."

During the past decade, Advanced ENT and Allergy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Advanced ENT and Allergy" are "Chronic Rhinitis" (2 trials) and "Chronic Rhinosinusitis" (2 trials). Many other conditions were trialed in "Advanced ENT and Allergy" in a lesser frequency.

Most popular intervention types in "Advanced ENT and Allergy" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "OPN-375" (2 trials), "InSeca Stylus" (1 trials) and "Radiofrequency Stylus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced ENT and Allergy" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Advanced ENT and Allergy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Advanced ENT and Allergy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advanced ENT and Allergy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".